HGITX
Price
$54.41
Change
+$0.44 (+0.82%)
Updated
Jun 6 closing price
Net Assets
10.5B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

HGITX vs VITSX

Header iconHGITX vs VITSX Comparison
Open Charts HGITX vs VITSXBanner chart's image
Hartford Core Equity R5
Price$54.41
Change+$0.44 (+0.82%)
VolumeN/A
Net Assets10.5B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
HGITX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGITX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGITX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. HGITX (10.5B). VITSX pays higher dividends than HGITX: VITSX (1.29) vs HGITX (0.61). HGITX was incepted earlier than VITSX: HGITX (18 years) vs VITSX (28 years). HGITX (0.45) is less costly to investors than VITSX (0.03). HGITX is a more actively managed with annual turnover of: 27.00 vs. VITSX (2.00). HGITX has a lower initial minimum investment than VITSX: HGITX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. HGITX (2.57). VITSX return over 5 years is better than : 80.96 vs. HGITX (60.33).
HGITXVITSXHGITX / VITSX
Total Expense Ratio0.450.031,500%
Annual Report Gross Expense Ratio0.450.031,500%
Fund Existence18 years28 years-
Gain YTD1.2380.833149%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10.5B1.82T1%
Annual Yield % from dividends0.611.2947%
Returns for 1 year2.5710.9723%
Returns for 3 years28.2140.3570%
Returns for 5 years60.3380.9675%
Returns for 10 years142.97180.4979%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.